Free Trial
OTCMKTS:MBVXQ

MabVax Therapeutics (MBVXQ) Stock Price, News & Analysis

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)
Free MBVXQ Stock Alerts
$0.02
+0.00 (+9.52%)
(As of 03/19/2020)
Compare
Today's Range
$0.02
▼
$0.02
50-Day Range
$0.02
▼
$0.02
52-Week Range
$0.00
▼
$0.30
Volume
1,300 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About MabVax Therapeutics

MabVax Therapeutics Holdings, Inc. is a clinical-stage drug development company. It is focused on discovering and developing small molecule drugs to treat cancer. TELINTRA is the Company's lead small molecule product candidate in clinical development for the treatment of blood disorders, including cancer. MabVax Therapeutics Holdings, Inc., formerly known as Telik, Inc., is based in San Diego, California.

MBVXQ Stock Price History

MBVXQ Stock News Headlines

August 23, 2023 | seekingalpha.com
FRTX Fresh Tracks Therapeutics, Inc.
October 7, 2021 | law360.com
MabVax Brass Slip Suit By Alleged Pump-And-Dump Investor
See More Headlines
Receive MBVXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MabVax Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/25/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MBVXQ
CUSIP
N/A
CIK
N/A
Web
www.mabvax.com
Phone
858-259-9405
Fax
650-845-7800
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

MBVXQ Stock Analysis - Frequently Asked Questions

How have MBVXQ shares performed in 2024?

MabVax Therapeutics' stock was trading at $0.0230 at the beginning of 2024. Since then, MBVXQ stock has increased by 0.0% and is now trading at $0.0230.
View the best growth stocks for 2024 here.

How do I buy shares of MabVax Therapeutics?

Shares of MBVXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MBVXQ) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Prepare for a recession unlike any other
American Hartford Gold Group
Will this $2 AI stock double overnight?
Behind the Markets
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold